American Association for Cancer Research Inaugurates the First Class of Fellows of the AACR Academy


Get Permission

The American Association for Cancer Research (AACR) inaugurated the first class of Fellows of the AACR Academy at the association’s annual meeting held this month in Washington, DC. The AACR Academy has been created to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer. These Fellows have been selected through a rigorous peer review process that evaluates individuals on the basis of their stellar scientific achievements in cancer research.

The inaugural class of Fellows was inducted into the AACR Academy on April 5, 2013, at the National Museum of Women in the Arts in Washington, DC.

Inaugural Fellows of the AACR Academy

Karen H. Antman, MD, Boston University School of Medicine

David Baltimore, PhD, California Institute of Technology

Françoise Barré-Sinoussi, PhD, Institut Pasteur

Paul Berg, PhD, Stanford University School of Medicine

Joseph R. Bertino, MD, The Cancer Institute of New Jersey; University of Medicine and Dentistry, Robert Wood Johnson Medical School; The Stem Cell Institute of N.J.

J. Michael Bishop, MD, G. W. Hooper Research Foundation; University of California, San Francisco

Mina J. Bissell, PhD, Lawrence Berkeley National Laboratory

Elizabeth H. Blackburn, PhD, University of California, San Francisco

Sydney Brenner, MB, BCh, DPhil, Founder, Acidophil, LLC; Salk Institute for Biological Studies

Angela H. Brodie, PhD, University of Maryland School of Medicine

Mario R. Capecchi, PhD, University of Utah School of Medicine; Howard Hughes Medical Institute

Webster K. Cavenee, PhD, Ludwig Institute for Cancer Research; University of California, San Diego

Martin Chalfie, PhD, Columbia University

Zhu Chen, MD, PhD, 12th Standing Committee of the National People’s Congress; 15th Chinese Peasants and Workers Democratic Party, Central Committee

Aaron J. Ciechanover, MD, DSc, Technion-Israel Institute of Technology

Bayard D. Clarkson, MD, Memorial Sloan-Kettering Cancer Center

Donald S. Coffey, PhD, Johns Hopkins University School of Medicine

Stanley N. Cohen, MD, Stanford University

Suzanne Cory, PhD, University of Melbourne

Carlo M. Croce, MD, The Ohio State University School of Medicine

Tom Curran, PhD, The Children’s Hospital of Philadelphia Research Institute; Perelman School of Medicine; University of Pennsylvania

Brian J. Druker, MD, Knight Cancer Institute, Oregon Health and Science University; Howard Hughes Medical Institute

Raymond N. DuBois, MD, PhD, The Biodesign Institute; Arizona State University

Sir Martin J. Evans, PhD, Cardiff University

Emmanuel Farber, MD, PhD, University of Toronto

Napoleone Ferrara, MD, Moores Cancer Center, University of California, San Diego

Isaiah J. Fidler, D.V.M., PhD, The University of Texas MD Anderson Cancer Center

Bernard Fisher, MD, University of Pittsburgh

Joseph F. Fraumeni Jr., MD, National Cancer Institute

Emil Frei III, MD, Dana-Farber Cancer Institute, Harvard Medical School

Elaine V. Fuchs, PhD, Rockefeller University; Howard Hughes Medical Institute

Judy E. Garber, MD, MPH, Dana-Farber Cancer Institute; Harvard Medical School

Walter Gilbert, PhD, Harvard University

Alfred G. Gilman, MD, PhD, University of Texas Southwestern Medical Center

Carol W. Greider, PhD, Johns Hopkins University School of Medicine

Roger C. L. Guillemin, MD, PhD, Salk Institute for Biological Studies

Sir John B. Gurdon, D.Phil, Wellcome Trust/Cancer Research U.K. Gurdon Institute

William N. Hait, MD, PhD, Global Head at Janssen Research and Development, LLC

Leland H. Hartwell, PhD, Arizona State University; Fred Hutchinson Cancer Research Center

Avram Hershko, MD, PhD, Technion-Israel Institute of Technology; New York University School of Medicine

James F. Holland, MD, Mount Sinai Medical Center

Jimmie C. Holland, MD, Memorial Sloan-Kettering Cancer Center

Waun Ki Hong, MD, The University of Texas MD Anderson Cancer Center

Leroy E. Hood, MD, PhD, University of Washington Molecular and Cellular Biology Program; Keck Graduate Institute of Applied Life Sciences

H. Robert Horvitz, PhD, Massachusetts Institute of Technology; MIT Koch Institute for Integrative Cancer Research; MIT McGovern Institute for Brain Research; Howard Hughes Medical Institute

Susan Band Horwitz, PhD, Albert Einstein Cancer Center; Albert Einstein College of Medicine

Sir R. Timothy Hunt, PhD, Clare Hall Laboratories, Cancer Research U.K.

Tony Hunter, PhD, Salk Institute Cancer Center; The Salk Institute for Biological Studies

Tyler Jacks, PhD, David H. Koch Institute for Integrative Cancer Research; Massachusetts Institute of Technology; Howard Hughes Medical Institute

Peter A. Jones, PhD, DSc, University of Southern California (USC) Norris Comprehensive Cancer Center

V. Craig Jordan, PhD, DSc, Lombardi Comprehensive Cancer Center, Georgetown University

Yuet Wai Kan, MD, University of California, San Francisco

Mary-Claire King, PhD, University of Washington

Eva Klein, MD, PhD, Karolinska Institutet

George Klein, MD, PhD, Karolinska Institutet

Alfred G. Knudson Jr., MD, PhD, Fox Chase Cancer Center

Brian K. Kobilka, MD, Stanford University School of Medicine

Margaret L. Kripke, PhD, The University of Texas MD Anderson Cancer Center

Philip Leder, MD, Harvard Medical School

Robert J. Lefkowitz, MD, Howard Hughes Medical Institute; Duke University Medical Center

Arnold J. Levine, PhD, Simons Center for Systems Biology, Institute for Advanced Study; Cancer Institute of New Jersey

Lawrence A. Loeb, MD, PhD, Joseph Goldstein Memorial Cancer Research Laboratory, University of Washington School of Medicine

Tak W. Mak, PhD, Ontario Cancer Institute, Princess Margaret Cancer Centre; University of Toronto

Lynn M. Matrisian, PhD, Pancreatic Cancer Action Network

Frank McCormick, PhD, Helen Diller Family Comprehensive Cancer Center; University of California, San Francisco

John Mendelsohn, MD, Sheik Kalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; MD Anderson Cancer Center

Donald Metcalf, MD, Professor Emeritus, University of Melbourne; Carden Fellow in Cancer Research, Division of Cancer and Hematology, the Walter and Eliza Hall Institute of Medical Research

Enrico Mihich, MD, Dana-Farber Cancer Institute

Beatrice Mintz, PhD, Fox Chase Cancer Center

Luc Montagnier, MD, World Foundation for AIDS Research and Prevention; Centre National de la Recherché Scientifique; Professor Emeritus, Pasteur Institute

Harold L. Moses, MD, Vanderbilt-Ingram Comprehensive Cancer Center

Sir Paul M. Nurse, PhD, Francis Crick Institute

Olufunmilayo I. Olopade, MD, University of Chicago Pritzker School of Medicine

Arthur B. Pardee, PhD, Harvard Medical School

Martine J. Piccart, MD, PhD, Université Libre de Bruxelles; Jules Bordet Institute

Sir Bruce A. J. Ponder, MB, BChir, PhD, Cancer Research U.K. Cambridge Research Institute; University of Cambridge; Cambridge University Hospitals

Sir Richard J. Roberts, PhD, New England Biolabs, Inc.

Irwin A. Rose, PhD, University of California, Irvine

Janet D. Rowley, MD, University of Chicago

Frederick Sanger, PhD, University of Cambridge

Alan C. Sartorelli, PhD, Yale University School of Medicine

Andrew V. Schally, PhD, University of Miami

Phillip A. Sharp, PhD, David H. Koch Institute for Integrative Cancer Research; Massachusetts Institute of Technology

Charles J. Sherr, MD, PhD, St. Jude Children’s Research Hospital; Howard Hughes Medical Institute

Osamu Shimomura, PhD, Boston University School of Medicine     

Dennis J. Slamon, MD, PhD, Revlon/UCLA Women’s Cancer Research Program, Jonsson Comprehensive Cancer Center; David Geffen School of Medicine, University of California, Los Angeles      

Oliver Smithies, D.Phil, University of North Carolina School of Medicine at Chapel Hill

Michael B. Sporn, MD, Geisel School of Medicine at Dartmouth

Louise C. Strong, MD, The University of Texas MD Anderson Cancer Center

Takashi Sugimura, MD, Toho University; National Cancer Center

Sir John E. Sulston, PhD, University of Manchester

Jack W. Szostak, PhD, Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital

Roger Y. Tsien, PhD, University of California, San Diego; Howard Hughes Medical Institute

Arthur C. Upton, MD, University of Medicine and Dentistry, Robert Wood Johnson Medical School

George F. Vande Woude, PhD, Van Andel Research Institute

Bert Vogelstein, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine; Howard Hughes Medical Institute

Peter K. Vogt, PhD, The Scripps Research Institute

Daniel D. Von Hoff, MD, Translational Genomics Research Institute; Mayo Clinic; Scottsdale Health Care; University of Arizona College of Pharmacy

Geoffrey M. Wahl, PhD, Salk Institute for Biological Studies

James D. Watson, PhD, Cold Spring Harbor Laboratory

Lee W. Wattenberg, MD, Masonic Cancer Center, University of Minnesota

Robert A. Weinberg, PhD, Massachusetts Institute of Technology; Ludwig/MIT Center for Molecular Oncology

John H. Weisburger, PhD, New York Medical College

Jane Cooke Wright, MD, Deceased (1919 – 2013)

Shinya Yamanaka, MD, PhD, Kyoto University; University of California, San Francisco    

Harald zur Hausen, MD, German Cancer Research Center



Advertisement

Advertisement



Advertisement